Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
European Radiology|June 14, 2015
Consensus report from the 7th International Forum for Liver Magnetic Resonance ImagingElmar M Merkle, Christoph J Zech, Carlo Bartolozzi, et al.
Liver Cancer|July 11, 2020
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus StatementsMasatoshi Kudo, Kwang-Hyub Han, Sheng-Long Ye, et al.
International Journal of Nanomedicine|August 14, 2012
The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)Haitham Amal, Lu Ding, Bin-bin Liu, et al.
Medical Oncology (Northwood, London, England)|February 21, 2015
Long-term outcomes and prognostic analysis of radiofrequency ablation for small hepatocellular carcinoma: 10-year follow-up in Chinese patientsLan Zhang, Ning-Lin Ge, Yi Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinomaZhengGang Ren, KangShun Zhu, HaiYan Kang, et al.
Cancer Medicine|February 1, 2018
Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15Gang Dong, Qiong-Dan Zheng, Min Ma, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|December 20, 2008
[Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection]Zheng-gang Ren, Yu-hong Gan, Jia Fan, et al.
Molecular & Cellular Proteomics : MCP|November 1, 2003
From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasisShi-Jian Ding, Yan Li, Ye-Xiong Tan, et al.
Journal of Cancer Research and Clinical Oncology|March 19, 2009
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinomaXin-Da Zhou, Zhao-You Tang, Jia Fan, et al.
BMC Cancer|March 4, 2018
Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON studySheng-Long Ye, Jiamei Yang, Ping Bie, et al.
Pageof 11